Denver’s Vibrant Art Scene on Display during Denver Arts Week
– The Mile High City’s vibrant and diverse arts and culture scene shines during the nine-day celebration with over 550 events. – DENVER, Nov. 3, 2023 /PRNewswire/ — The 17th Annual Denver Arts Week, a celebration of Denver’s vibrant and diverse arts and culture scene
Smart Speaker Market size to grow by USD 16.65 billion from 2022 to 2027- Technavio
NEW YORK, Nov. 3, 2023 /PRNewswire/ — The smart speaker market by end-user (residential and commercial), distribution channel (offline and online), and geography (North America, Europe, APAC, South America, and Middle East and Africa) – Forecast and Analysis 2023-2027 report has been a
Global Proteomics Market Set to Reach $39.03 Billion by 2023, Fueled by Advancements in Drug Discovery and Disease Diagnosis
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Proteomics Market (by Product, Application, Technology, End User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The global proteo
Global Turbocharger Market to Reach $18.67 Billion by 2023, Growing at a CAGR of 6.90%
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Turbocharger Market (by Engine Type, Technology, Distribution Channel, Vertical, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Outlook Therapeutics, Inc. – OTLK
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veradigm Inc. – MDRX
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-652
Asia Pacific Leads the Travel Retail Market Due to Thriving Tourism and Growing Number of Airports
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Travel Retail Market (by Product Type, Sale Channel, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)” report has been added to ResearchAndMarkets.com’s offering. The global travel retail mar
REGENXBIO Presents Positive One Year Data from Phase II ALTITUDE® Trial of ABBV-RGX-314 for Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
ABBV-RGX-314 continues to be well tolerated in 50 patients from dose levels 1 and 2 (Cohorts 1-3) with no drug-related serious adverse eventsDose level 2 prevented disease progression and reduced vision-threatening events in non-proliferative diabetic retinopathy patients at 1 Year 70.8% of patient
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DICK’S Sporting Goods, Inc. – DKS
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of DICK’S Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS). Such investors are advised to contact Robert S. Willoughby at newaction@pom
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SCYNEXIS, Inc. – SCYX
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SCYNEXIS, Inc. (“SCYNEXIS” or the “Company”) (NASDAQ: SCYX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-652